Effect of transcranial magnetic stimulation on focal hand dystonia: a systematic review and meta-analysis.
7 affiliations
- 1Department of Neurology, Duke University School of Medicine, Durham, NC, United States.
- 2Medical Scientist Training Program, Duke University School of Medicine, Durham, NC, United States.
- 3Department of Psychiatry, and Behavioral Sciences, Duke University School of Medicine, Durham, NC, United States.
- 4Department of Electrical and Computer Engineering, Duke University, Durham, NC, United States.
- 5Department of Neurosurgery, Duke University, Durham, NC, United States.
- 6Department of Biomedical Engineering, Duke University, Durham, NC, United States.
- 7Duke Institute for Brain Sciences, Duke University, Durham, NC, United States.
Abstract
Background
Focal hand dystonia (FHD) is a rare and disabling movement disorder with limited treatment options. Transcranial magnetic stimulation (TMS) has shown promise as a non-invasive neuromodulation therapy for dystonia, but its efficacy in FHD remains unclear due to heterogeneity across prior studies and mixed results from broader noninvasive brain stimulation meta-analyses.Objective
To systematically review and synthesize the effects of TMS on behavioral symptoms in individuals with FHD.Methods
A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines. PubMed, Embase, and Web of Science were searched through January 2026 for studies applying TMS in individuals with FHD. Studies reporting behavioral outcome measures of dystonia severity were included. Random-effects meta-analyses were performed to estimate pooled effect sizes using Hedges' g for (1) pre-versus post-TMS comparisons and (2) active-TMS versus sham-TMS comparisons. Study quality and risk of bias were assessed using Cochrane Risk of Bias and PEDro scales. Publication bias was assessed using funnel plot and Egger's test.Results
Nine studies met inclusion criteria, comprising a total of 111 individuals with FHD. Meta-analysis demonstrated a moderate and statistically significant improvement in dystonia symptoms following TMS compared with pre-TMS (Hedges' g = 0.36, 95% CI [0.17, 0.56], p < 0.001). In studies including sham controls (n = 8; 102 participants), active-TMS was associated with significantly greater symptom improvement compared with sham stimulation (Hedges' g = 0.35, 95% CI [0.12, 0.57], p = 0.002). Between study heterogeneity was low for both analyses, and no evidence of significant publication bias was detected.Conclusion
TMS is associated with a mild to moderate improvement in behavioral symptoms of FHD. These findings support further investigation of TMS as a non-invasive therapeutic option for FHD and highlight the need for larger, well-designed clinical trials to optimize stimulation parameters and assess durability of treatment effects.
Related
- Efficacy of High‐Frequency Transcranial Magnetic Stimulation Therapy for Depression With Insomnia Symptoms: A Systematic Review and Meta‐Analysis Based on Randomized Controlled Trials
- Systematic review and meta-analysis on the efficacy and safety of combining repetitive transcranial magnetic stimulation with sertraline for adolescent depression in China
- Effects of transcranial direct current stimulation on gait and balance under dual-task conditions in older adults: a systematic review and meta-analysis
- Transcranial magnetic stimulation-based multisite neuromodulation for motor recovery after spinal cord injury: a structured narrative review
- Transcranial Pulse Stimulation in Parkinson's Disease: A Systematic Review.
BibTeX
@article{simsek2026effect,
title = {{Effect of transcranial magnetic stimulation on focal hand dystonia: a systematic review and meta-analysis.}},
author = {Zeynep B Simsek and Patrick J Mulcahey and Michael W Lutz and Angel V Peterchev and Noreen Bukhari-Parlakturk},
journal = {Dystonia (Lausanne, Switzerland)},
year = {2026},
month = aug,
doi = {10.3389/dyst.2026.16666},
url = {https://europepmc.org/article/MED/42904005},
note = {CC BY},
}
RIS
TY - JOUR
TI - Effect of transcranial magnetic stimulation on focal hand dystonia: a systematic review and meta-analysis.
AU - Zeynep B Simsek
AU - Patrick J Mulcahey
AU - Michael W Lutz
AU - Angel V Peterchev
AU - Noreen Bukhari-Parlakturk
PY - 2026
DA - 2026/08/13
JO - Dystonia (Lausanne, Switzerland)
DO - 10.3389/dyst.2026.16666
UR - https://europepmc.org/article/MED/42904005
AB - Background Focal hand dystonia (FHD) is a rare and disabling movement disorder with limited treatment options. Transcranial magnetic stimulation (TMS) has shown promise as a non-invasive neuromodulation therapy for dystonia, but its efficacy in FHD remains unclear due to heterogeneity across prior studies and mixed results from broader noninvasive brain stimulation meta-analyses.Objective To systematically review and synthesize the effects of TMS on behavioral symptoms in individuals with FHD.Methods A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines. PubMed, Embase, and Web of Science were searched through January 2026 for studies applying TMS in individuals with FHD. Studies reporting behavioral outcome measures of dystonia severity were included. Random-effects meta-analyses were performed to estimate pooled effect sizes using Hedges' g for (1) pre-versus post-TMS comparisons and (2) active-TMS versus sham-TMS comparisons. Study quality and risk of bias were assessed using Cochrane Risk of Bias and PEDro scales. Publication bias was assessed using funnel plot and Egger's test.Results Nine studies met inclusion criteria, comprising a total of 111 individuals with FHD. Meta-analysis demonstrated a moderate and statistically significant improvement in dystonia symptoms following TMS compared with pre-TMS (Hedges' g = 0.36, 95% CI [0.17, 0.56], p < 0.001). In studies including sham controls (n = 8; 102 participants), active-TMS was associated with significantly greater symptom improvement compared with sham stimulation (Hedges' g = 0.35, 95% CI [0.12, 0.57], p = 0.002). Between study heterogeneity was low for both analyses, and no evidence of significant publication bias was detected.Conclusion TMS is associated with a mild to moderate improvement in behavioral symptoms of FHD. These findings support further investigation of TMS as a non-invasive therapeutic option for FHD and highlight the need for larger, well-designed clinical trials to optimize stimulation parameters and assess durability of treatment effects.
SN - 2813-2106
ER -